Zhang Zhipeng, Wang Yun, Xu Shaohui, Yu Yanna, Hussain Abid, Shen Yuanyuan, Guo Shengrong
School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
J Mater Chem B. 2017 Jul 21;5(27):5464-5472. doi: 10.1039/c7tb01253e. Epub 2017 Jun 30.
The design of an ideal drug delivery system with targeted recognition and minimized premature release, especially controlled and specific release that is triggered by endogenous and exogenous dual-stimuli, is a great challenge. A biotin receptor-targeted, near-infrared (NIR) irradiation and redox responsive nano-system has now been developed. The nano-system was constructed by filling the interior of Au nanocages with doxorubicin as a chemotherapy agent trapped in tetradecanol, followed by surface conjugation of biotinylated poly(ethylene glycol)-poly(curcumin-dithiodipropionic acid) (Biotin-PEG-PCDA) as a macromolecular chemosensitizer. Once the nano-system had been delivered into MCF-7/ADR cells by biotin receptor mediated recognition and endocytosis, drug release was triggered by degradation of PCDA via a glutathione induced redox reaction in combination with a solid-liquid change of tetradecanol by photothermal effects under NIR irradiation, which could minimize premature drug release and then maximize the therapeutic efficacy.
设计一种具有靶向识别功能且能将过早释放降至最低的理想药物递送系统,尤其是由内源性和外源性双重刺激触发的可控且特异性释放,是一项巨大挑战。目前已开发出一种靶向生物素受体、近红外(NIR)照射和氧化还原响应的纳米系统。该纳米系统的构建方法是,将作为化疗药物的阿霉素填充到金纳米笼内部,阿霉素被困在十四醇中,然后将生物素化的聚(乙二醇)-聚(姜黄素-二硫代二丙酸)(生物素-聚乙二醇-PCDA)作为大分子化学增敏剂进行表面共轭。一旦该纳米系统通过生物素受体介导的识别和内吞作用被递送至MCF-7/ADR细胞中,PCDA会通过谷胱甘肽诱导的氧化还原反应降解,同时在近红外照射下通过光热效应使十四醇发生固-液变化,从而触发药物释放,这可以最大限度地减少药物过早释放,进而最大化治疗效果。